Bristol, Merck, AbbVie face House committee probe over China trials

[Capsule with the flag of China, spilling small pills from open halves.]
Love Employee/iStock via Getty Images

* The House Select Committee on China has opened investigations into Bristol Myers Squibb (BMY [https://seekingalpha.com/symbol/BMY]), Merck (MRK [https://seekingalpha.com/symbol/MRK]), Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), and AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]) over the companies' clinical trials at Chinese military sites or hospitals.
* In a letter to Bristol CEO Chris Boerner, Chair John Moolenaar (R-Mich.) wrote that based on information from clinicaltrials.gov, the drugmaker sponsored trials at Chinese military hospitals and in Xinjiang, which [https://chinaselectcommittee.house.gov/sites/evo-subsites/selectcommitteeontheccp.house.gov/files/evo-media-document/chairman-moolenaar-letter-to-bms-june-29_2026.pdf] "is the epicenter of the CCP’s genocide targeting Uyghurs and other ethnic and religious minorities."
* Moolenaar expressed more positive sentiment [https://files.constantcontact.com/f0eecb46901/7ce2c65d-4e4f-4c62-81c5-2560781cacbd.pdf] to Pfizer CEO Albert Bourla. "I understand that Pfizer will no longer sponsor trials in Xinjiang and at PRC military hospitals in the future. I commend this decision, and I would like to learn more about the company’s due diligence efforts that led to it. Furthermore, I would also like to understand how Pfizer’s decision affects its partnerships with Chinese biotechnology companies and associated due diligence efforts."

MORE ON BRISTOL MYERS SQUIBB, PFIZER

* Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff [https://seekingalpha.com/article/4918091-pfizer-why-being-bullish-makes-sense-despite-the-patent-cliff]
* Antibody-Drug Conjugates: Not Quite Worked Out Yet [https://seekingalpha.com/article/4917846-antibody-drug-conjugates-not-quite-worked-out-yet]
* Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in Obesity - Slideshow [https://seekingalpha.com/article/4915806-pfizer-inc-pfe-discusses-new-phase-iib-data-and-development-plans-for-berobenatide-glpminus-1]
* RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs [https://seekingalpha.com/news/4608608-rfk-jr-ends-emergency-use-authorizations-covid-19-drugs]
* FDA commissioner contenders down to three - report [https://seekingalpha.com/news/4607782-fda-commissioner-contenders-down-three]